<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    1445513
   </pmid>
   <datecreated>
    <year>
     1992
    </year>
    <month>
     04
    </month>
    <day>
     23
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1992
    </year>
    <month>
     04
    </month>
    <day>
     23
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2010
    </year>
    <month>
     09
    </month>
    <day>
     07
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0959-8138
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       304
      </volume>
      <issue>
       6824
      </issue>
      <pubdate>
       <year>
        1992
       </year>
       <month>
        Feb
       </month>
       <day>
        15
       </day>
      </pubdate>
     </journalissue>
     <title>
      BMJ (Clinical research ed.)
     </title>
     <isoabbreviation>
      BMJ
     </isoabbreviation>
    </journal>
    <articletitle>
     Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
    </articletitle>
    <pagination>
     <medlinepgn>
      405-12
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="OBJECTIVE" nlmcategory="OBJECTIVE">
      To establish whether treatment with diuretic or beta blocker in hypertensive older adults reduces risk of stroke, coronary heart disease, and death.
     </abstracttext>
     <abstracttext label="DESIGN" nlmcategory="METHODS">
      Randomised, placebo controlled, single blind trial.
     </abstracttext>
     <abstracttext label="SETTING" nlmcategory="METHODS">
      226 general practices in the MRC general practice research framework.
     </abstracttext>
     <abstracttext label="SUBJECTS" nlmcategory="METHODS">
      4396 patients aged 65-74 randomised to receive diuretic, beta blocker, or placebo. Patients had mean systolic pressures of 160-209 mm Hg and mean diastolic pressures less than 115 mm Hg during an eight week run in and were not taking antihypertensive treatment.
     </abstracttext>
     <abstracttext label="INTERVENTION" nlmcategory="METHODS">
      Patients were randomised to atenolol 50 mg daily; hydrochlorothiazide 25 mg or 50 mg plus amiloride 2.5 mg or 5 mg daily; or placebo. The regimens were adjusted to achieve specified target pressures. Mean follow up was 5.8 years.
     </abstracttext>
     <abstracttext label="MAIN OUTCOME MEASURES" nlmcategory="METHODS">
      Strokes, coronary events, and deaths from all causes.
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      Both treatments reduced blood pressure below the level in the placebo group. Compared with the placebo group, actively treated subjects (diuretic and beta blocker groups combined) had a 25% (95% confidence interval 3% to 42%) reduction in stroke (p = 0.04), 19% (-2% to 36%) reduction in coronary events (p = 0.08), and 17% (2% to 29%) reduction in all cardiovascular events (p = 0.03). After adjusting for baseline characteristics the diuretic group had significantly reduced risks of stroke (31% (3% to 51%) p = 0.04), coronary events (44% (21% to 60%), p = 0.0009), and all cardiovascular events (35% (17% to 49%), p = 0.0005) compared with the placebo group. The beta blocker group showed no significant reductions in these end points. The reduction in strokes was mainly in non-smokers taking the diuretic.
     </abstracttext>
     <abstracttext label="CONCLUSION" nlmcategory="CONCLUSIONS">
      Hydrochlorothiazide and amiloride reduce the risk of stroke, coronary events, and all cardiovascular events in older hypertensive adults.
     </abstracttext>
    </abstract>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Comparative Study
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Randomized Controlled Trial
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     ENGLAND
    </country>
    <medlineta>
     BMJ
    </medlineta>
    <nlmuniqueid>
     8900488
    </nlmuniqueid>
    <issnlinking>
     0959-535X
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Diuretics
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      2609-46-3
     </registrynumber>
     <nameofsubstance>
      Amiloride
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      29122-68-7
     </registrynumber>
     <nameofsubstance>
      Atenolol
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      58-93-5
     </registrynumber>
     <nameofsubstance>
      Hydrochlorothiazide
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      J Hypertens. 1990 Jun;8(6):547-55
     </refsource>
     <pmid version="1">
      2165089
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Hypertens. 1990 Feb;8(2):147-52
     </refsource>
     <pmid version="1">
      2162877
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1985 Jun 15;1(8442):1349-54
     </refsource>
     <pmid version="1">
      2861311
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Hypertens. 1987 Oct;5(5):561-72
     </refsource>
     <pmid version="1">
      2892881
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br Med J (Clin Res Ed). 1986 Nov 1;293(6555):1145-51
     </refsource>
     <pmid version="1">
      3094811
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 1987 Aug 13;317(7):426-32
     </refsource>
     <pmid version="1">
      3614286
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br Heart J. 1985 Oct;54(4):351-6
     </refsource>
     <pmid version="1">
      4052276
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br Med J (Clin Res Ed). 1981 Oct 31;283(6300):1151-3
     </refsource>
     <pmid version="1">
      6794796
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Jpn Heart J. 1981 Jan;22(1):75-85
     </refsource>
     <pmid version="1">
      7012398
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1981 Mar 27;245(12):1225-9
     </refsource>
     <pmid version="1">
      7206111
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Med J Aust. 1980 Jul 12;2(1):27-31
     </refsource>
     <pmid version="1">
      7432261
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1989 Jun 10;298(6687):1552-6
     </refsource>
     <pmid version="1">
      2503114
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1990 Apr 7;335(8693):827-38
     </refsource>
     <pmid version="1">
      1969567
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1991 Nov 23;338(8778):1281-5
     </refsource>
     <pmid version="1">
      1682683
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Acta Med Scand. 1981;210(3):221-9
     </refsource>
     <pmid version="1">
      7293840
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Bull World Health Organ. 1980;58(1):113-30
     </refsource>
     <pmid version="1">
      6966542
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1970 Mar 7;1(7645):485-9
     </refsource>
     <pmid version="1">
      4190177
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1987 Mar 14;1(8533):581-4
     </refsource>
     <pmid version="1">
      2881129
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Intern Med. 1988 Jun;148(6):1280-8
     </refsource>
     <pmid version="1">
      2897834
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Heart J. 1988 Jan;115(1 Pt 2):276-81
     </refsource>
     <pmid version="1">
      3336995
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      BMJ. 1992 May 9;304(6836):1245
     </refsource>
     <pmid version="1">
      1355380
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      BMJ. 1992 Jun 20;304(6842):1631; author reply 1631-2
     </refsource>
     <pmid version="1">
      1352716
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      BMJ. 1992 Jun 20;304(6842):1630-1; author reply 1631-2
     </refsource>
     <pmid version="1">
      1352715
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      BMJ. 1992 Apr 18;304(6833):1054
     </refsource>
     <pmid version="1">
      1350231
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      BMJ. 1992 Mar 7;304(6827):639
     </refsource>
     <pmid version="1">
      1348440
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      BMJ. 1992 Jun 20;304(6842):1631; author reply 1631-2
     </refsource>
     <pmid version="1">
      1445573
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Amiloride
     </descriptorname>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Atenolol
     </descriptorname>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cardiovascular Diseases
     </descriptorname>
     <qualifiername majortopicyn="N">
      prevention &amp; control
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cerebrovascular Disorders
     </descriptorname>
     <qualifiername majortopicyn="Y">
      prevention &amp; control
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Coronary Disease
     </descriptorname>
     <qualifiername majortopicyn="Y">
      prevention &amp; control
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Diuretics
     </descriptorname>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Drug Therapy, Combination
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Hydrochlorothiazide
     </descriptorname>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Hypertension
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Sex Factors
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Single-Blind Method
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC1995577
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1992
     </year>
     <month>
      2
     </month>
     <day>
      15
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1992
     </year>
     <month>
      2
     </month>
     <day>
      15
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1992
     </year>
     <month>
      2
     </month>
     <day>
      15
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     1445513
    </articleid>
    <articleid idtype="pmc">
     PMC1995577
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

